Cardiac rehabilitation to reduce fall risk in elderly patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on the implementation of cardiac rehabilitation for elderly patients who have recently experienced acute cardiovascular events. The rehabilitation program consists of three phases: in-hospital rehabilitation, early outpatient rehabilitation, and long-term maintenance. The goal is to improve functional capacity and maintain independence in daily activities while addressing the increased risk of falls due to factors like muscle weakness and orthostatic hypotension. The study evaluates the effectiveness of exercise training, with or without medication, in mitigating these risks.

Why it matters

Who can join: the full rules

Inclusion Criteria:

\- Age \> 65 years

Recent acute cardiac event, including:

1. Cardiac surgery (CABG, aortic and/or mitral valve replacement, mitral valvuloplasty, or combined CABG + valve surgery)
2. Recent myocardial infarction treated with percutaneous revascularization
3. Episode of acute heart failure

Exclusion Criteria:

Persistent clinical instability, defined as:

* Marked hypotension (BP ≤ 95/60 mmHg) or hypertension (BP ≥ 160/100 mmHg)
* Bradycardia (HR \< 50 bpm) or tachycardia (HR \> 115 bpm)
* Resting dyspnea
* Signs and symptoms of infection

Where it's running

• IRCCs San Raffaele
  Rome, Rm, Italy Recruiting

Study contacts

• Study coordinator: Lucia Gatta
• Email: lucia.gatta@sanraffaele.it
• Phone: +390652253440

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Abnormal menstrual bleeding in women on antithrombotic drugs after heart surgery

  This study looks at whether women on blood thinners after heart surgery have abnormal menstrual bleeding and what factors might put some at higher risk.

  Recruiting Shanghai Zhongshan Hospital · Shanghai, Shanghai Municipality · NCT07870941

• AI-powered ECG to help diagnose and predict outcomes in heart disease

  Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.

  Recruiting Inha University Hospital · Incheon, Incheon · NCT07856472

• Colchicine for preventing cardiovascular disease in adults with type 2 diabetes

  A 24-week study will test whether low-dose colchicine can help protect blood vessels in adults with type 2 diabetes who have not yet developed artery disease, compared with a placebo.

  Recruiting Phase 2 Tan Tock Seng Hospital · Singapore, Singapore · NCT07837934

• Optimised Cardio-Renal Care for CKD and heart disease

  This study tests whether a specialised Cardio-Renal Clinic can improve heart and kidney health and quality of life for adults with chronic kidney disease and cardiovascular disease.

  Recruiting Odense University Hospital · Svendborg · NCT07835828

• Dignity Therapy for Older Adults in Long-Term Care

  This study tests dignity therapy to help people 65 and older in long-term care see their lives as meaningful and preserve their sense of self.

  Recruiting Kaohsiung Medical University Chung-Ho Memorial Hospital · Kaohsiung City · NCT07824401

• Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients

  This study tests inhaled mosliciguat versus placebo in people with PH-ILD to see if it helps with their condition.

  Recruiting at 3 sites Phase 3 Pulmovant, Inc. · Kissimmee, Florida and 2 other locations · NCT07816185

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.